Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Study for Patients With Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab 12-month Intensive Pharmacovigilance Protocol
- Status
- COMPLETED
- Phase
- N/A
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox
- Status
- TERMINATED
- Phase
- PHASE2
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2